5-methylcytosine has been researched along with Nervous System Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Fang, J; Gao, Y | 1 |
Lu, GZ; Wang, J; Zhang, KX; Zhao, XH | 1 |
Jin, P; Yao, B | 1 |
An, R; Ming, GL; Shin, J; Song, H; Weng, YL | 1 |
Li, X; Shu, Q; Sun, W; Zang, L | 1 |
Bi, C; Cai, B; Liang, J; Yang, F; Zhao, L | 1 |
6 review(s) available for 5-methylcytosine and Nervous System Diseases
Article | Year |
---|---|
RNA 5-methylcytosine modification and its emerging role as an epitranscriptomic mark.
Topics: 5-Methylcytosine; Animals; Humans; Neoplasms; Nervous System Diseases; Protein Biosynthesis; RNA Processing, Post-Transcriptional; Transcriptome | 2021 |
Research progress on 5hmC and TET dioxygenases in neurodevelopment and neurological diseases.
Topics: 5-Methylcytosine; Animals; Dioxygenases; Humans; Mixed Function Oxygenases; Nervous System; Nervous System Diseases; Neurogenesis; Proto-Oncogene Proteins | 2017 |
Cytosine modifications in neurodevelopment and diseases.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; DNA-Cytosine Methylases; Humans; Models, Molecular; Nervous System Diseases; Neurogenesis | 2014 |
DNA modifications and neurological disorders.
Topics: 5-Methylcytosine; Brain; Cytosine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation; Humans; Nervous System Diseases; Neurons | 2013 |
From development to diseases: the role of 5hmC in brain.
Topics: 5-Methylcytosine; Aging; Animals; Cytosine; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Humans; Nervous System Diseases; Neurons | 2014 |
Physiological and pathological implications of 5-hydroxymethylcytosine in diseases.
Topics: 5-Methylcytosine; CpG Islands; Dioxygenases; DNA (Cytosine-5-)-Methyltransferases; DNA Demethylation; DNA Methylation; DNA-Binding Proteins; Embryonic Development; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Mixed Function Oxygenases; Neoplasms; Nervous System Diseases; Promoter Regions, Genetic; Proto-Oncogene Proteins | 2016 |